Broadfin Healthcare Master Fund Ltd, 10% Owner at Recro Pharma, Inc. (REPH), sold 151,474 shares at $9.84 ($1.5M) on 2017-12-13, disclosed to the SEC on 2017-12-14.
Open-market sale of $1.5M REPH by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.80 | 50,000 | $490K | 32.9% |
| 2 | $9.80 | 50,000 | $490K | 32.9% |
| 3 | $9.89 | 100 | $989 | 0.1% |
| 4 | $10.00 | 25,000 | $250K | 16.8% |
| 5 | $9.80 | 8,237 | $81K | 5.4% |
| 6 | $9.80 | 8,237 |
| $81K |
| 5.4% |
| 7 | $9.84 | 9,900 | $97K | 6.5% |
| Total | $9.84 avg | 151,474 | $1.5M | 100% |
| Filing → |
| REPH | SELL | 2017-12-07 | $1.0M | — | Filing → |
| PETX | SELL | 2017-12-01 | $5.1M | — | Filing → |
| REPH | SELL | 2017-11-30 | $2.1M | — | Filing → |